Eagle Health Investments LP Buys American Well Corp, DexCom Inc, Outset Medical Inc, Sells Thermo Fisher Scientific Inc, Jaws Acquisition Corp, Agios Pharmaceuticals Inc

• New Purchases: AMWL, KYMR, CCCC, ARVN, OLK,
• Added Positions: DXCM, OM, INSP, MRTX, ARGX, AZN, AXNX, ADPT, HUM, UTHR, BPMC, FDMT,
• Reduced Positions: AGIO, VRTX, IQV, NTRA,
• Sold Out: TMO, JWS, DFHT,

For the details of Eagle Health Investments LP's stock buys and sells, go to https://www.gurufocus.com/guru/eagle+health+investments+lp/current-portfolio/portfolio

1. AstraZeneca PLC (AZN) - 399,789 shares, 8.72% of the total portfolio. Shares added by 12.05%
2. Humana Inc (HUM) - 47,721 shares, 7.69% of the total portfolio. Shares added by 6.23%
3. IQVIA Holdings Inc (IQV) - 85,277 shares, 7.52% of the total portfolio. Shares reduced by 14.87%
4. Natera Inc (NTRA) - 163,194 shares, 6.74% of the total portfolio. Shares reduced by 3.09%
5. Alnylam Pharmaceuticals Inc (ALNY) - 108,179 shares, 6.68% of the total portfolio.

Eagle Health Investments LP initiated holding in American Well Corp. The purchase prices were between $10.05 and $18.73, with an estimated average price of $14.48. The stock is now traded at around $11.429300. The impact to a portfolio due to this purchase was 3.33%. The holding were 727,600 shares as of 2021-06-30.

Eagle Health Investments LP initiated holding in Kymera Therapeutics Inc. The purchase prices were between $31.08 and $51.95, with an estimated average price of $43.34. The stock is now traded at around $53.630000. The impact to a portfolio due to this purchase was 0.65%. The holding were 37,000 shares as of 2021-06-30.

Eagle Health Investments LP initiated holding in C4 Therapeutics Inc. The purchase prices were between $30.39 and $42.18, with an estimated average price of $35.89. The stock is now traded at around $39.260000. The impact to a portfolio due to this purchase was 0.65%. The holding were 47,200 shares as of 2021-06-30.

Eagle Health Investments LP initiated holding in Arvinas Inc. The purchase prices were between $60.45 and $84.26, with an estimated average price of $69.37. The stock is now traded at around $75.450000. The impact to a portfolio due to this purchase was 0.64%. The holding were 23,000 shares as of 2021-06-30.

Eagle Health Investments LP initiated holding in Olink Holding AB. The purchase prices were between $26.65 and $39.47, with an estimated average price of $34.42. The stock is now traded at around $32.610000. The impact to a portfolio due to this purchase was 0.5%. The holding were 40,000 shares as of 2021-06-30.

Eagle Health Investments LP added to a holding in DexCom Inc by 147.83%. The purchase prices were between $323.96 and $431.72, with an estimated average price of $383.25. The stock is now traded at around $435.470000. The impact to a portfolio due to this purchase was 3.17%. The holding were 34,200 shares as of 2021-06-30.

Eagle Health Investments LP added to a holding in Outset Medical Inc by 91.16%. The purchase prices were between $41.49 and $59.92, with an estimated average price of $51.05. The stock is now traded at around $42.125000. The impact to a portfolio due to this purchase was 1.61%. The holding were 186,000 shares as of 2021-06-30.

Eagle Health Investments LP added to a holding in Inspire Medical Systems Inc by 49.66%. The purchase prices were between $164.93 and $242.23, with an estimated average price of $198.55. The stock is now traded at around $177.670000. The impact to a portfolio due to this purchase was 1.31%. The holding were 56,053 shares as of 2021-06-30.

Eagle Health Investments LP added to a holding in Mirati Therapeutics Inc by 59.07%. The purchase prices were between $144 and $179.73, with an estimated average price of $160.98. The stock is now traded at around $164.135000. The impact to a portfolio due to this purchase was 1.26%. The holding were 57,900 shares as of 2021-06-30.

Eagle Health Investments LP added to a holding in argenx SE by 24.86%. The purchase prices were between $257.11 and $319.92, with an estimated average price of $284.1. The stock is now traded at around $312.685000. The impact to a portfolio due to this purchase was 1.16%. The holding were 53,232 shares as of 2021-06-30.

Eagle Health Investments LP added to a holding in Axonics Inc by 20.31%. The purchase prices were between $51.39 and $66.9, with an estimated average price of $59.02. The stock is now traded at around $59.150000. The impact to a portfolio due to this purchase was 0.91%. The holding were 234,565 shares as of 2021-06-30.

Eagle Health Investments LP sold out a holding in Thermo Fisher Scientific Inc. The sale prices were between $441 and $508.24, with an estimated average price of $471.32.

Eagle Health Investments LP sold out a holding in Jaws Acquisition Corp. The sale prices were between $12.53 and $14.86, with an estimated average price of $13.38.

Eagle Health Investments LP sold out a holding in Deerfield Healthcare Technology Acquisitions Corp. The sale prices were between $12.12 and $15.12, with an estimated average price of $13.12.